Lifeline BioTechnologies CEO Featured in Exclusive Interview with WallSt.net
March 29 2007 - 7:00AM
PR Newswire (US)
NEW YORK, March 29 /PRNewswire/ -- On March 27, Jim Holmes, Chief
Executive Officer for Lifeline BioTechnologies, Inc. (Pink Sheets:
LBTN) updated the investment community in an exclusive interview
with http://www.wallst.net/ . Topics covered in the interview
include an overview of the Company and the markets it serves,
recent press releases, current capitalization, upcoming strategic
and financial milestones. To hear the interview in its entirety,
visit http://www.wallst.net/ , and click on "Interviews." The
interview can be accessed either by locating the company's ticker
symbol under the appropriate exchange on the left-hand column of
the "Interviews" section of the site, or by entering the company's
ticker symbol in the Search Archive window. About Lifeline
BioTechnologies, Inc.: Lifeline BioTechnologies, Inc. is a company
with innovative medical technologies committed to the improvement
of the quality of life through exceptional health care systems.
These technologies focus on prevention, early detection, diagnosis
and quick recovery of a number of disease conditions. The company's
technologies, designed to assist in the early detection of cancers,
deal with cutting-edge innovation to assist practicing physicians
in the delivery of quality medical care. For more information,
please visit http://www.lbtn.com/ . About WallSt.net:
http://www.wallst.net/ is owned and operated by WallStreet Direct,
Inc., a wholly owned subsidiary of Financial Media Group, Inc. The
website is a leading provider of financial news, media, tools and
community-driven applications for investors. http://www.wallst.net/
offers visitors free membership to its in-depth executive
interviews, exclusive editorial content, breaking news, and several
proprietary applications. In addition to its website, WallStreet
Direct organizes investor conferences, publishes a newspaper, and
provides multimedia advertising solutions to small and mid-sized
publicly traded companies. We are expecting to receive two hundred
eighty dollars from Lifeline BioTechnologies, Inc. for the
dissemination of this press release. For a complete list of our
advertisers, and advertising relationships, visit
http://www.wallst.net/disclaimer/disclaimer.asp . (Logo:
http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO )
http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO
http://photoarchive.ap.org/ DATASOURCE: WallStreet Direct, Inc.
CONTACT: Nick Iyer of Digital Wall Street, Inc., +1-800-4-WALL-ST
Web site: http://www.wallst.net/disclaimer/disclaimer.asp Web site:
http://www.lbtn.com/ Web site: http://www.wallst.net/
Copyright